ANA Investigates Biomarkers for Alzheimer Disease

 

Published in partnership with American Neurological Association

In this podcast, David Holtzman, MD, talks about the established biomarkers for Alzheimer disease, potential biomarkers being investigated, and how long it may take for these biomarker tests to make it to the bedside.

David Holtzman

David M. Holtzman, MD, is the Andrew B. and Gretchen P. Jones Professor of Neurology, Charlotte and Paul Hagemann Professor of Neurology, chairman of the Department of Neurology, and professor in the Molecular Biology and Pharmacology Department at Washington University School of Medicine in St. Louis, as well as Neurologist-in-Chief at Barnes-Jewish Hospital in St. Louis, Missouri.

For more ANA investigates podcasts, visit our partners at the American Neurological Association.